Blog
IOM report highlights benefits of pediatric drug studies
A report released Feb. 29th by the Institute of Medicine (IOM) provided a review of the benefits of current federal laws that offer incentives for or require drug and biologic developers to conduct pediatric studies. The report also highlighted several areas where...
Late Payments Stalling Clinical Trials
Check out what our friend and colleague Christine Pierre had to say in this February 21, 2012 article by Ann Neuer of bioitworld.com. Christine gave her thoughts on the current budget woes that exist within the clinical trial process. As she shares, budgets are...
Join us at the Upcoming HBA Indiana Event
Join us at the Forum Conference and Events Center in Fishers, Indiana for a lively presentation by Dr. Lois Frankel. This presentation is sponsored by by Roche Diagnostics. Dr. Frankel is a bestselling author focusing on helping women get the most they want from...
Sunshine Act Limiting US Drug Research?
In a recent article, The Association of Clinical Research Organizations (ACRO) has voiced its concern that the Sunshine Act may have negative effects on US drug research. The Sunshine Act requires the reporting of payments made by biopharma to physicians and was...
Social Media Increasing Patient Recruitment?
Is social media the holy grail to our clinical study recruitment woes? According to a recent Mayo Clinic pilot study, social media not only increased the number of volunteers in clinical trials but also obtained demographically diverse patient groups in a faster and...